Art

J-GLOBAL ID：201902234001142617   Reference number：19A2824169

Serum Antibody Against NY-ESO-1 and XAGE1 Antigens Potentially Predicts Clinical Responses to Anti-Programmed Cell Death-1 Therapy in NSCLC

NY-ESO-1およびXAGE1抗原に対する血清抗体はNSCLCにおける抗プログラム細胞死-1療法に対する臨床反応を潜在的に予測する【JST・京大機械翻訳】

Author (22)： Ohue Yoshihiro (Department of Respiratory Medicine, Kawasaki Medical School, Okayama, Japan) ,  Kurose Koji (Department of Respiratory Medicine, Kawasaki Medical School, Okayama, Japan) ,  Karasaki Takahiro (Department of Thoracic Surgery, The University of Tokyo, Tokyo, Japan) ,  Isobe Midori (Department of Respiratory Medicine, Kawasaki Medical School, Okayama, Japan) ,  Yamaoka Takaaki (Department of Respiratory Medicine, Kawasaki Medical School, Okayama, Japan) ,  Futami Junichiro (Department of Medical Bioengineering, Graduate School of Natural Science and Technology, Okayama University, Okayama, Japan) ,  Irei Isao (Department of Pathology, Kawasaki Medical School, Okayama, Japan) ,  Masuda Takeshi (Department of Respiratory Internal Medicine, Hiroshima University Hospital, Hiroshima, Japan) ,  Fukuda Masaaki (Department of Respiratory Medicine, The Japanese Red Cross Nagasaki Genbaku Hospital, Nagasaki, Japan) ,  Kinoshita Akitoshi (Department of Respiratory Medicine, Nagasaki Prefecture Shimabara Hospital, Nagasaki, Japan) ,  Matsushita Hirokazu (Department of Immunotherapeutics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan) ,  Matsushita Hirokazu (Cancer Immunology Data Multi-level Integration Unit, Medical Science Innovation Hub Program, RIKEN, Tokyo, Japan) ,  Shimizu Katsuhiko (Department of General Thoracic Surgery, Kawasaki Medical School, Okayama, Japan) ,  Nakata Masao (Department of General Thoracic Surgery, Kawasaki Medical School, Okayama, Japan) ,  Hattori Noboru (Department of Respiratory Internal Medicine, Hiroshima University Hospital, Hiroshima, Japan) ,  Yamaguchi Hiroyuki (Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan) ,  Fukuda Minoru (Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan) ,  Fukuda Minoru (Clinical Oncology Center, Nagasaki University Hospital, Nagasaki, Japan) ,  Nozawa Ryohei (Faculty of Health and Welfare Services Administration, Kawasaki University of Medical Welfare, Okayama, Japan) ,  Kakimi Kazuhiro (Department of Immunotherapeutics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan) ,  Kakimi Kazuhiro (Cancer Immunology Data Multi-level Integration Unit, Medical Science Innovation Hub Program, RIKEN, Tokyo, Japan) ,  Oka Mikio (Department of Immuno-Oncology, Kawasaki Medical School, Okayama, Japan)
Material： Journal of Thoracic Oncology
Volume： 14  Issue： 12  Page： 2071-2083  Publication year： 2019 
JST Material Number： W3145A  ISSN： 1556-0864  Document type： Article
Article type： 原著論文  Country of issue： Netherlands (NLD)  Language： ENGLISH (EN)

Abstract/Point： Programmed cell death-1 (PD-1)...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=19A2824169&from=J-GLOBAL&jstjournalNo=W3145A") }}

Thesaurus term： antibody titer ,  immunohistochemistry ,  biomarker ,  *antigen ,  immersional wetting ,  tumor immunity ,  population (statistics) ,  testis ,  *Serum ,  Multivariate Analysis ,  *antibody ,  Mutation ,  survival ratio ,  *Death ,  *non-small cell lung cancer

Author keywords (5)： Biomarker ,  Anti-programmed death 1 therapy ,  NSCLC ,  Cancer-testis antigen ,  Serum antibody

JST classification (1)： Tumors(=neoplasms)of respiratory system  (GI04000G)

Terms in the title (9)： NY-ESO-1 ,  抗原 ,  血清 ,  抗体 ,  NSCLC ,  プログラム細胞死 ,  療法 ,  臨床 ,  予測